Patients with a higher level of post-treatment AFP within 1 year, and after 1 year, those with a history of more than two treatments for HCC or those with diabetes mellitus, which are related to post-treatment eGFR, require careful attention regarding the possibility of HCC recurrence. Here, AFP is linked to diabetes mellitus.